Virginia Regulatory Town Hall
Health and Human Resources
Department of Health Professions
Board of Medicine
Petition 372
Petition Information
Petition Title Replace naloxone co-prescription requirement with FDA-approved opioid-reversal agents
Date Filed 7/27/2022    [Transmittal Sheet]
Petitioner Todd Lacksonen 
Petitioner's Request

The petitioner requests that the Board amend 18VAC85-21-40 to replace the requirement to co-prescribe naloxone with certain medications or conditions with a requirement to co-prescribe an FDA-approved opioid-reversal agent. 

Agency's Plan

The petition for rulemaking will be published in the Virginia Register of Regulations on August 29, 2022. The petition will also be published on the Virginia Regulatory Town Hall at to receive public comment, which will open on August 29, 2022 and will close on September 19, 2022. The Board will consider the petition and all comments in support or opposition at the next meeting after the close of public comment, currently scheduled for October 6, 2022. 

Comment Period Began 8/29/2022    Ended 9/19/2022
Virginia Register Announcement Submitted on 7/27/2022
The Virginia Register of Regulations
Published on: 8/29/2022     Volume: 39  Issue: 1
Agency Decision Take no action [Transmittal Sheet]    
Response Date 10/6/2022
Decision Publication Date Published on: 11/7/2022     Volume: 39  Issue: 6
Agency Decision Summary

The Board considered the petition at its October 6, 2022 meeting and decided to take no action at this time. The Board intends to review the entire chapter devoted to opioid and buprenorphine prescribing following the issuance of new guidance by the Centers for Disease Control and Prevention. The Board will include this issue as a revision to be considered along with any other changes to Chapter 21. 

Contact Information
Name / Title: William L. Harp, M.D.  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Henrico, 23233
Email Address:
Telephone: (804)367-4558    FAX: (804)527-4429    TDD: ()-